insights_auto
Why is GALT down 2.81%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$2.94
arrow_downward
-2.81%(-0.085) 1D
Nov 17, 1:04:34 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.11
High
$3.20
Low
$2.92
Mkt. cap
295.99M
Avg. vol.
201.39K
Volume
134.20K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.11
High
$3.20
Low
$2.92
Mkt. cap
295.99M
Avg. vol.
201.39K
Volume
134.20K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
The Globe and Mail
·
3 hours ago
Analysts Are Bullish on Top Healthcare Stocks: Galectin Therapeutics (GALT), Jade Biosciences (JBIO)
GuruFocus
·
22 hours ago
Galectin Therapeutics (GALT) Posts Q3 Earnings Beat with Narrower Loss
scanx.trade
·
1 day ago
Galectin Therapeutics Q3 Results: Loss narrows 69% YoY to $0.04 per share
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com